Encompass Health declares quarterly dividend

BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE:EHC), a major operator of inpatient rehabilitation hospitals in the United States, has announced a quarterly cash dividend of $0.17 per share, representing a 0.67% yield. The dividend is payable on April 15, 2025, to shareholders on record as of April 1, 2025. InvestingPro data reveals the company has maintained dividend payments for 13 consecutive years, demonstrating strong commitment to shareholder returns.

The company, which operates 166 hospitals across 38 states and Puerto Rico, is recognized for providing high-quality rehabilitative care. With a market capitalization of $10.24 billion and revenue growth of 11.91% over the last twelve months, Encompass Health has demonstrated strong market presence. The company has been acknowledged by Fortune as one of the World’s Most Admired Companies™ and by Forbes as one of America’s Most Trusted Companies.

This dividend declaration follows a pattern of Encompass Health’s commitment to returning value to its shareholders and is aligned with its financial policies. The company’s performance in the healthcare sector has been marked by its adherence to advanced technology and innovative treatments, which are fundamental to its patient care philosophy.

While the announcement of the dividend is a forward-looking statement, it is based on current information and subject to various factors that could affect the company’s financial condition or results of operations. According to InvestingPro analysis, the company maintains a GREAT financial health score and trades near its 52-week high, though investors should note that six analysts have recently revised their earnings expectations downward. These factors could include changes in federal, state, or local regulations, economic conditions, disruptions in information systems, and changes in healthcare reimbursement policies, among others. For detailed insights and additional ProTips, access the comprehensive Pro Research Report available on InvestingPro.

The information provided in this article is based on a press release statement from Encompass Health Corporation. Investors and interested parties are reminded that forward-looking statements involve risks and uncertainties, and actual events or results may differ materially from those anticipated.

Encompass Health has not indicated any changes to its dividend policy or future financial strategies. The company remains focused on maintaining its position in the healthcare industry and continues to monitor the various factors that could impact its operations and financial performance.

In other recent news, Encompass Health Corp’s fourth-quarter earnings exceeded Wall Street expectations, with EBITDA showing a 14% year-over-year growth. This strong performance was driven by robust same-store volumes and margin improvements. Following these results, KeyBanc Capital Markets analyst Matthew Gillmor raised the company’s price target to $120, maintaining an Overweight rating. Gillmor highlighted Encompass Health’s growth strategy through new developments and joint ventures as a key factor in its success. He noted the company’s structural margin advantage in the inpatient rehabilitation facility sector, which could sustain growth over the next 5 to 10 years.

Additionally, KeyBanc Capital Markets expressed a positive outlook for the healthcare services sector in 2025, emphasizing the potential for hospitals to benefit from favorable volume environments. Within this context, Encompass Health is seen as a stock that could steadily increase in value due to its patient volume benefits and some protection from policy changes. KeyBanc also upgraded Acadia Healthcare (NASDAQ:ACHC) Company to an Overweight rating, indicating a positive shift in perspective. The firm remains cautious on Evolent Health (NYSE:EVH) but suggests potential momentum following updates on payer contracts.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.